Tag Archives: Baker IDI Heart and Diabetes Institute

The Baker Institute supports push for better management of conflicts of interest

Professor Garry Jennings, Director of the Baker IDI Heart & Diabetes Institute, has responded to recent Croakey posts raising concerns about his organisation’s close ties with industry. It seems there will be no more Baker staff appearing in pharmaceutical advertorials. He writes:
“The Croakey posting on Conflict of Interest points to both the diversity of views [...]

The Baker, the NHMRC and conflicts of interest

Following the recent post about the Baker IDI Heart and Diabetes Institute’s latest foray into pharmaceutical marketing, Croakey asked both the Baker and the NHMRC for comment.
No word yet from the Baker, but Professor Warwick Anderson, ceo of the NHMRC, sent this comment:
“The Australian Code for the Responsible Conduct of Research (issued jointly by NHMRC, [...]

Crikey Register of Influence raises more questions for the Baker Institute

The Crikey Register of Influence – which details links between opinion leaders, organisations and industry marketing campaigns – has been updated.
The new entries are Professor Simon Stewart, Head, Preventive Cardiology at the Baker IDI Heart and Diabetes Institute, and his colleague, Dr Melinda Carrington, General Manager of the Baker’s Disease Management and Preventative Programs.
They appeared [...]

Has anyone the time, interest or funding for these stories?

In case there are any researchers or journalists out there with too much time on their hands, here are two ideas for stories or research projects.
• What is the role of the media in Mr Ward’s death?
The 4 Corners report on the death of Mr Ward, an Aboriginal man who was incarcerated in the most [...]

The Baker drug deal found in breach

The controversial sponsorship deal between Sanofi-Aventis and the Baker IDI Heart and Diabetes Institute has been found to be in breach of the Medicines Australia code of conduct.
Under the deal, for every Plavix script dispensed through retail pharmacy in 2009, Sanofi-Aventis agreed to donate 25 cents to support the Baker’s medical research and preventative health [...]

The Baker boss responds to the alarm bells

Garry Jennings. director of the Baker IDI Heart and Diabetes Institute, has sent in the following response to concerns raised at Croakey and elsewhere, with a link to a question and answer document on the Institute’s website:
“We thank everyone for their comments. This is an innovative donation arrangement so we are not surprised at the [...]

Who’s the loser with this clever drug company campaign?

You’ve got to hand it to Sanofi-Aventis.
At the same time as the Vioxx case before the Federal Court is producing an alarming string of stories about the hazards of overly close ties between doctors and pharma (as an example, see this story in the Oz and this one in The Age), Sanofi-Aventis has enticed a [...]